Vaginal Native Tissues Repair for Pelvic Organ Prolapse
TAPP
1 other identifier
interventional
214
1 country
9
Brief Summary
The aim of the study is to assess at one year the effectiveness of the vaginal patch plastron in comparison of the anterior colporraphy through a combined definition of success: anatomic and functional.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2019
Longer than P75 for not_applicable
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 13, 2019
CompletedFirst Posted
Study publicly available on registry
March 15, 2019
CompletedStudy Start
First participant enrolled
September 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 27, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 27, 2028
ExpectedAugust 29, 2023
August 1, 2023
6 years
March 13, 2019
August 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of the prolapse surgery
The success rate of the prolapse surgery defined by a composite of objective and subjective measures: * Anatomic success defined by Aa and Ba values \<0 in Pelvic Organ Prolapse Quantification System (POP-Q) AND * Subjective success through reliable condition-specific quality-of-life questionnaires: * A negative response to the question "Do you usually have a bulge or something falling out that you can see or feel in your vaginal area?" (question 3 of the Pelvic Floor Distress Inventory (PFDI-20)) AND * Range score of Patient Global Impression of Improvement (PGI-I) 1 or 2 AND * No need for other treatment for prolapse (surgical nor medical)
1 year
Secondary Outcomes (5)
Rate of the prolapse surgery
1 year
Rate of post-operative complications
45 Days
Sexual function
1 year
Rate of the prolapse surgery
2 years
Rate of the prolapse surgery
3 years
Study Arms (2)
Arm A
ACTIVE COMPARATORArm B
EXPERIMENTALInterventions
It will be delimitate a rectangular vaginal strip which will be isolated from the anterior colpocele. The superior edge of the strip is placed 2 cm from the urethral orifice. After lateral vesico-vaginal dissection, the paravesical fossae will be wide opened to repair the tendinous arches. The vaginal plastron will be fixed to the tendinous arch of the pelvic fascia by 3 lateral stitches (anterior/ lateral/ posterior) on each side of the plastron. After, the plastron will be tensioning and the cystocele will be suspended. The closure of the vaginal wall will end the procedure.
It will be make a midline incision of the anterior vaginal wall from the urethrovesical junction to the vaginal apex or anterior fornix. The vaginal epithelium will be separated from the underlying fibromuscular layer (Halban Fascia) after the midline incision. Midline plication of the fibromuscular layer will be obtained by interrupted horizontal stiches. The closure of the vaginal wall will end the procedure.
Eligibility Criteria
You may qualify if:
- Patient at 50 years of age or older
- Symptomatic primary prolapse of the anterior vaginal wall defined by Aa and/or Ba points ≥0 according to the POP-Q system
- A positive response to the question "Do you usually have a bulge or something falling out that you can see or feel in your vaginal area?" (question 3 of the PFDI-20)
- Able to give informed consent
- Performans Status score ≤ 2
You may not qualify if:
- Patient with need for surgical treatment for myorraphy of levator ani muscles
- Patient with previous surgical cystocele repair.
- Patient with evolving gynaecologic cancer.
- Pregnancy or wish for future pregnancy, lactating woman.
- Inability to participate in study follow-up or to provide informed consent.
- Lack of social insurance .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
CHU de Bordeaux
Bordeaux, 33000, France
CH de Brive
Brive-la-Gaillarde, 19100, France
CHU de Clermont Ferrand
Clermont-Ferrand, 63100, France
CH de Gueret
Guéret, 23000, France
CHU de Limoges
Limoges, 87000, France
CHU de Saint-Etienne
Saint-Etienne, 42000, France
CHU de Toulouse - Paule de Viguier
Toulouse, 31059, France
CHU de Toulouse - Rangueil
Toulouse, 31400, France
CH de Tulle
Tulle, 19000, France
Related Publications (1)
Lacorre A, Vidal F, Campagne-Loiseau S, Marin B, Aubard Y, Siegerth F, Mesnard C, Chantalat E, Hocke C, Gauthier T. Protocol for a randomized controlled trial to assess two procedures of vaginal native tissue repair for pelvic organ prolapse at the time of the questioning on vaginal prosthesis: the TAPP trial. Trials. 2020 Jul 8;21(1):624. doi: 10.1186/s13063-020-04512-x.
PMID: 32641096DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 13, 2019
First Posted
March 15, 2019
Study Start
September 27, 2019
Primary Completion
September 27, 2025
Study Completion (Estimated)
March 27, 2028
Last Updated
August 29, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share